Analyst Price Targets — EHAB
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 1:12 am | — | UBS | $13.80 | $13.60 | TheFly | Enhabit downgraded to Neutral from Buy at UBS |
| February 23, 2026 6:26 pm | — | Jefferies | $13.80 | $13.60 | TheFly | Enhabit downgraded to Hold from Buy at Jefferies |
| February 23, 2026 3:25 pm | — | Leerink Partners | $13.80 | $13.60 | TheFly | Enhabit price target raised to $13.80 from $9.50 at Leerink |
| February 23, 2026 3:22 pm | — | Truist Financial | $13.80 | $13.60 | TheFly | Enhabit price target raised to $13.80 from $10.50 at Truist |
| January 22, 2026 11:47 am | Michael Wiederhorn | Oppenheimer | $14.00 | $10.74 | TheFly | Enhabit upgraded to Outperform from Perform at Oppenheimer |
| January 8, 2026 8:03 am | — | Wolfe Research | $12.00 | $9.51 | StreetInsider | UBS Upgrades Enhabit Home Health & Hospice (EHAB) to Buy |
| January 7, 2026 12:05 pm | — | Truist Financial | $10.50 | $9.44 | TheFly | Enhabit initiated with a Hold at Truist |
| December 16, 2025 1:39 pm | — | Jefferies | $12.00 | $9.73 | TheFly | Enhabit price target raised to $12 from $11 at Jefferies |
| December 9, 2024 9:41 am | Brian Tanquilut | Jefferies | $9.50 | $7.73 | StreetInsider | Jefferies Upgrades Enhabit Home Health & Hospice (EHAB) to Buy |
| May 14, 2024 6:14 am | Whit Mayo | Leerink Partners | $8.50 | $8.64 | TheFly | Enhabit upgraded to Market Perform from Underperform at Leerink |
Latest News for EHAB
Enhabit (NYSE: EHAB - Get Free Report) is anticipated to release its Q4 2025 results after the market closes on Wednesday, March 4th. Analysts expect Enhabit to post earnings of $0.14 per share and revenue of $270.5590 million for the quarter. Parties may visit the the company's upcoming Q4 2025 earning results page for the latest
NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Enhabit Inc. (NYSE: EHAB) related to its…
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - February 24, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Enhabit, Inc. ("Enhabit" or the "Company") (NYSE: EHAB) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Kinderhook Industries, LLC ("Kinderhook") for…
Enhabit (EHAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, LLC. Under the terms of the proposed transaction, shareholders of Enhabit will receive $13.80 per share in cash. KSF is seeking to determine whether this consideration and…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EHAB.
U.S. House Trading
No House trades found for EHAB.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.